186 related articles for article (PubMed ID: 12412204)
1. CC chemokine receptor 5 and interleukin-1 receptor antagonist gene polymorphisms in patients with primary Sjögren's syndrome.
Petrek M; Cermáková Z; Hutyrová B; Miceková D; Drábek J; Rovensky J; Bosák V
Clin Exp Rheumatol; 2002; 20(5):701-3. PubMed ID: 12412204
[TBL] [Abstract][Full Text] [Related]
2. IL-1 receptor antagonist (IL-1RA) gene polymorphism in Sjögren's syndrome and rheumatoid arthritis.
Perrier S; Coussediere C; Dubost JJ; Albuisson E; Sauvezie B
Clin Immunol Immunopathol; 1998 Jun; 87(3):309-13. PubMed ID: 9646842
[TBL] [Abstract][Full Text] [Related]
3. B-cell activating factor genetic variants in lymphomagenesis associated with primary Sjogren's syndrome.
Nezos A; Papageorgiou A; Fragoulis G; Ioakeimidis D; Koutsilieris M; Tzioufas AG; Moutsopoulos HM; Voulgarelis M; Mavragani CP
J Autoimmun; 2014 Jun; 51():89-98. PubMed ID: 23845207
[TBL] [Abstract][Full Text] [Related]
4. Chemokine receptor 5 Δ32 polymorphism and systemic lupus erythematosus, vasculitis, and primary Sjogren's syndrome. Meta-analysis of possible associations.
Lee YH; Kim JH; Song GG
Z Rheumatol; 2014 Nov; 73(9):848-55. PubMed ID: 24599359
[TBL] [Abstract][Full Text] [Related]
5. Polymorphism in the TNF-alpha gene promoter at position -1031 is associated with increased circulating levels of TNF-alpha, myeloperoxidase and nitrotyrosine in primary Sjögren's syndrome.
Cay HF; Sezer I; Dogan S; Felek R; Aslan M
Clin Exp Rheumatol; 2012; 30(6):843-9. PubMed ID: 22703762
[TBL] [Abstract][Full Text] [Related]
6. Th2 cytokine genotypes are associated with a milder form of primary Sjogren's syndrome.
Pertovaara M; Antonen J; Hurme M
Ann Rheum Dis; 2006 May; 65(5):666-70. PubMed ID: 16166103
[TBL] [Abstract][Full Text] [Related]
7. Presence of apolipoprotein E epsilon4 allele predisposes to early onset of primary Sjogren's syndrome.
Pertovaara M; Lehtimäki T; Rontu R; Antonen J; Pasternack A; Hurme M
Rheumatology (Oxford); 2004 Dec; 43(12):1484-7. PubMed ID: 15328426
[TBL] [Abstract][Full Text] [Related]
8. Fas gene promoter polymorphisms in primary Sjögren's syndrome.
Mullighan CG; Heatley S; Lester S; Rischmueller M; Gordon TP; Bardy PG
Ann Rheum Dis; 2004 Jan; 63(1):98-101. PubMed ID: 14672901
[TBL] [Abstract][Full Text] [Related]
9. Homozygosity for the 168His variant of the minor histocompatibility antigen HA-1 is associated with reduced risk of primary Sjögren's syndrome.
Harangi M; Kaminski WE; Fleck M; Orsó E; Zeher M; Kiss E; Szekanecz Z; Zilahi E; Marienhagen J; Aslanidis C; Paragh G; Bolstad AI; Jonsson R; Schmitz G
Eur J Immunol; 2005 Jan; 35(1):305-17. PubMed ID: 15593299
[TBL] [Abstract][Full Text] [Related]
10. Impact of the leucocyte immunoglobulin-like receptor A3 (LILRA3) on susceptibility and subphenotypes of systemic lupus erythematosus and Sjögren's syndrome.
Du Y; Su Y; He J; Yang Y; Shi Y; Cui Y; Luo C; Wu X; Liu X; Hu F; Ma X; Zheng L; Zhang J; Zuo X; Sheng Y; Wu L; Zhang X; Guo J; Li Z
Ann Rheum Dis; 2015 Nov; 74(11):2070-5. PubMed ID: 24906639
[TBL] [Abstract][Full Text] [Related]
11. The CCR5 delta 32 polymorphism (rs333) is not associated with Sjögren's syndrome or Type 1 Diabetes in Colombians.
Maier-Moore JS; Cañas CA; Tobón G; Arango A; Anaya JM; Scofield RH
Clin Immunol; 2013 Aug; 148(2):206-8. PubMed ID: 23773920
[No Abstract] [Full Text] [Related]
12. FAS -670A>G promoter polymorphism is associated with soluble Fas levels in primary Sjögren's syndrome.
Treviño-Talavera BA; Palafox-Sánchez CA; Muñoz-Valle JF; Orozco-Barocio G; Navarro-Hernández RE; Vázquez-Del Mercado M; García de la Torre I; Oregon-Romero E
Genet Mol Res; 2014 Jul; 13(3):4831-8. PubMed ID: 25062418
[TBL] [Abstract][Full Text] [Related]
13. TNFR1-383 A˃C polymorphism association with clinical manifestations in primary Sjögren's syndrome patients.
Fletes-Rayas AL; Palafox-Sánchez CA; Muñoz-Valle JF; Orozco-Barocio G; Navarro-Hernández RE; Oregon-Romero E
Genet Mol Res; 2016 Jun; 15(2):. PubMed ID: 27323176
[TBL] [Abstract][Full Text] [Related]
14. IkappaBalpha promoter polymorphisms in patients with primary Sjögren's syndrome.
Ou TT; Lin CH; Lin YC; Li RN; Tsai WC; Liu HW; Yen JH
J Clin Immunol; 2008 Sep; 28(5):440-4. PubMed ID: 18600435
[TBL] [Abstract][Full Text] [Related]
15. Th1 and Th2 polymorphisms in Sjögren's syndrome and rheumatoid arthritis.
de Souza TR; de Albuquerque Tavares Carvalho A; Duarte ÂP; Porter SR; Leão JC; Gueiros LA
J Oral Pathol Med; 2014 Jul; 43(6):418-26. PubMed ID: 24393164
[TBL] [Abstract][Full Text] [Related]
16. Association of transforming growth factor beta1 and tumor necrosis factor alpha polymorphisms with anti-SSB/La antibody secretion in patients with primary Sjögren's syndrome.
Gottenberg JE; Busson M; Loiseau P; Dourche M; Cohen-Solal J; Lepage V; Charron D; Miceli C; Sibilia J; Mariette X
Arthritis Rheum; 2004 Feb; 50(2):570-80. PubMed ID: 14872501
[TBL] [Abstract][Full Text] [Related]
17. Immunoglobulin KM and GM gene polymorphisms modify the clinical presentation of primary Sjögren's syndrome.
Pertovaara M; Hurme M; Antonen J; Pasternack A; Pandey JP
J Rheumatol; 2004 Nov; 31(11):2175-80. PubMed ID: 15517630
[TBL] [Abstract][Full Text] [Related]
18. No evidence for an association between the -871 T/C promoter polymorphism in the B-cell-activating factor gene and primary Sjögren's syndrome.
Gottenberg JE; Sellam J; Ittah M; Lavie F; Proust A; Zouali H; Sordet C; Sibilia J; Kimberly RP; Mariette X; Miceli-Richard C
Arthritis Res Ther; 2006; 8(1):R30. PubMed ID: 16507129
[TBL] [Abstract][Full Text] [Related]
19. Interleukin-1 receptor antagonist VNTR-polymorphism in inflammatory bowel disease.
Vijgen L; Van Gysel M; Rector A; Thoelen I; Esters N; Ceelen T; Vangoidsenhoven E; Vermeire S; Rutgeerts P; Van Ranst M
Genes Immun; 2002 Nov; 3(7):400-6. PubMed ID: 12424621
[TBL] [Abstract][Full Text] [Related]
20. Analysis of the insertion/deletion related polymorphism within T cell antigen receptor beta variable genes in primary Sjögren's syndrome.
Lawson CA; Donaldson IJ; Bowman SJ; Shefta J; Morgan AW; Gough A; Isaacs JD; Griffiths B; Emery P; Pease CT; Boylston AW
Ann Rheum Dis; 2005 Mar; 64(3):468-70. PubMed ID: 15708895
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
